{"name":"ApcinteX Ltd","slug":"apcintex-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxNeDFEc1dNT3h5VGNyVW1XZ2czWFJnTFNCeGR3X3RKbWw4ZG1LTmluTFZ0emdEakptam1DaHVHTUwxM3VpZGJGYlFNN2k5a0V2VWU4d0hOaWZtdURaQ3U4OE1OSXRfRHB6QmpGcktGNnN0bkN0Rk41Zm5mSmVuM3gzZUs5M01FeHF3bWp3cWo2eG5VRmpxUjc3MURmdm9sei16Qk1xVlFya1FEWmZ4QXBNRjNpVFRrTmV4Z2dLWUlCeVpQWmtmWnlqVUV4T0xzaU9obzVZZ2tWcUZxQTQzbEswcWRhZ182b2JLSzlpZUFn?oc=5","date":"2026-03-31","type":"pipeline","source":"FinancialContent","summary":"The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals - FinancialContent","headline":"The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQdGtHS0prWERqRG4tNUhDaUU5WmhjSTNabm9MbFVHTzY0TlU2VXFISFR2emhKX2NwOWRReXlwMlU1Vk1ULWpNWDJxcE9mZnRPOXFnWDhWUnQ1VDVBUVlYZmJ6Wm1tZ0lER3hnV2pWd2RCM1h0LWx5NnE1bDVLRy1rN3lUUUpsR1c1aFhTLVFCY1pZQTNUM3ZFOXgtSTBwU0dDdjFLaHpjQlo2dUZVUWt3eTlKVFN4R0NBUzQxQ1V0ejB2czkxc3ptc2FBVlBEaWVWT1N5SVNaWWctS3Y1UVE?oc=5","date":"2025-04-21","type":"pipeline","source":"PR Newswire","summary":"Roche's HEMLIBRA Achieves Significant Uptake Across Key Hemophilia A Markets | DelveInsight - PR Newswire","headline":"Roche's HEMLIBRA Achieves Significant Uptake Across Key Hemophilia A Markets | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNM2VUT1BKUjUxMVhFYnF2bm81ZkVVU3JKbk1hSTNPYjdkT2lkRDZLZFlnM3pMSjVnN0taT25xdTBtQlRqZUlHWXBLSndmTktTVUtXOTlFTXJzN3pCcTQ2d2ZEajNxczl4OW1Xenpfd01ScGRaNktjdkVOTFY2cTM2QQ?oc=5","date":"2024-03-27","type":"pipeline","source":"Yahoo Finance","summary":"Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, SerpinPC, AskBio009, PF-06838435/fida, Marstacimab, FLT180a, Concizumab, Fitusiran - Y","headline":"Hemophilia B Drug Market Size and Share to Grow by 2032, Assesses DelveInsight | Key Emerging Therapies - CSL222, Serpin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQX0ZLbldHSk1USmZBMDMwb1YyQ2ZSRGdTV09pd3NrVXA3a2liczBFbk5FNTdJMmFab0ZBUmdwQ05oOXVSWGtvbU5EaU5ySm55NUpIZmxrMW1VS3ZSUnZ2NzkxT25nanFUaXRIbWxZN2Jmc1Mwb21GRTluVDdRZnEtQXNFelRQMnU4VHRJcVkzcnVkQXBOSjNCVXJpY0tzSkpfVWVFSk1Sc0l6OVd5NWc?oc=5","date":"2021-06-23","type":"pipeline","source":"Pharmaceutical Technology","summary":"Centessa Pharmaceuticals: forging a new path for pharma R&D - Pharmaceutical Technology","headline":"Centessa Pharmaceuticals: forging a new path for pharma R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNV2FvUUItMEMxbnB6OEl6ZFc0US1iaUx0NUJ5SUlfa3BiWkdkQVpMTFR4QWJUZWFsWFdLU0JGcHdGTDN0TEpJelhLcWY5b2F5SjJ5MEUxNkxOYld4M0RLRTRmSGRicDNyQThmc1FHZFlKRWJKam9QLXBNOGczM2x0ZGtvTWdBOFE5c2N6ZmlHaXdPQk82TXJtMUVnMzBBanZzNmlpekw0M3R3aXVKaXpuMEpsYl9ERjlUWDg3M3RjMjdVbVdjV3NiTVZLTkFNQ0ZiVEtRVXpqU3hqRUdZRUZHVlJJeS1zOGFVeHlkcGJxLWp0ZDRodXljSDVZa3pJT3ZIN2ZWTDJtdWxpcDBRdnFiZWFjOVdFRjJt?oc=5","date":"2021-02-15","type":"deal","source":"marketscreener.com","summary":"Centessa Pharmaceuticals Limited acquired Palladio Biosciences, Inc. from Medicxi Ventures (UK) LLP and others. - marketscreener.com","headline":"Centessa Pharmaceuticals Limited acquired Palladio Biosciences, Inc. from Medicxi Ventures (UK) LLP and others.","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}